A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in adult subjects with rheumatoid arthritis receiving Study Drug or placebo.
We’ve supported more than 150 infectious disease studies, leading to the approval of 13 important marketed products.
PRA Exceeds Tough Enrollment Goals
A Phase IIb, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the safety, tolerability and efficacy of Study Drug in…
Volunteer for a Study
At PRA, we perform independent research to determine the safety and effectiveness of new drugs. We are continuously looking for volunteers who want…